SUBSCRIBE
SUBSCRIBE
News   FDA

Novo Nordisk A/S’s Novoeight Wins FDA Approval for Hemophilia A

October 16, 2013 | 
1 min read

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Denmark’s Novo Nordisk has received a licence application approval in the United States for its haemophilia drug Novoeight.

Help employers find you! Check out all the jobs and post your resume.

FDA Approvals Europe
Food and Drug Administration (FDA) Novo Nordisk
MORE ON THIS TOPIC
Novo Nordisk advertising flags and logo on facade
Regulatory
Novo Nordisk Snags Kidney Disease Expansion for Ozempic in Europe
December 12, 2024
 · 
1 min read
 · 
Kate Goodwin
Sign outside BioNTech's building in Germany
Breast cancer
BioNTech Builds Case for PD-L1/VEGF Bispecific With Promising Breast Cancer Data
December 11, 2024
 · 
2 min read
 · 
Tristan Manalac
Mental health, illness ,brain development ,medical treatment concept, messy lines of thinks in human head , vector illustration
Neurodegenerative disease
UniQure Clears Path to Accelerated Approval for Huntington’s Gene Therapy
December 10, 2024
 · 
2 min read
 · 
Tristan Manalac
A handshake of businessmen. Modern design with a positive context. Concept of help, support, and agreement between businessmen. Modern art collage, trendy magazine style.
Mergers & acquisitions
Novo, Catalent $16.5B Deal Wins EU Blessing as US Antitrust Scrutiny Mounts
December 9, 2024
 · 
2 min read
 · 
Tristan Manalac